RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in developing tumor-targeted small molecule medicines that utilize radioisotopes, particularly focusing on alpha-emitting isotopes like Actinium-225 for the treatment of solid tumors. RayzeBio aims to improve cancer treatment outcomes by creating a robust pipeline of radiopharmaceuticals targeting validated oncology drug targets. Its portfolio includes multiple drug candidates at various stages of development, ranging from discovery to late-stage clinical programs, addressing significant market opportunities in the field of cancer therapeutics.
Inspirna is a biopharmaceutical company focused on discovering and developing innovative therapeutic targets and drugs for various cancer subtypes, including melanoma, colorectal cancer, and triple-negative breast cancer. Utilizing a proprietary microRNA-based target discovery platform, Inspirna identifies and validates novel post-transcriptionally regulated targets, leading to the creation of first-in-class therapeutics. The company has developed several promising drug candidates, such as RGX-104, an oral small molecule designed for treating solid tumors, RGX-202, which targets cancer metabolism in gastrointestinal cancers, and RGX-019, a monoclonal antibody aimed at disrupting pathways that promote tumor progression and metastasis. Founded in 2010 and headquartered in New York, Inspirna strives to transform the lives of cancer patients by providing safe and effective therapies for metastatic disease.
LimaCharlie is a provider of Security Infrastructure as a Service (SIaaS), offering a platform designed to streamline information security management. By delivering security tools on-demand, LimaCharlie enables businesses to efficiently manage their cloud security while significantly reducing costs and effort. The platform includes endpoint-driven security tools, telemetry storage, and a comprehensive incident response pipeline, allowing users to create custom detection and response rules. Additionally, LimaCharlie equips organizations with the necessary resources to operate a Managed Security Service Provider (MSSP) or Security Operations Center (SOC). The availability of APIs further allows users to build and monetize their own security products, making it a versatile solution in the field of information security.
Redbud Brands is a brand development studio focused on creating disruptive companies in the consumer space, particularly within the premium consumer packaged goods sector. The firm partners with visionary founders and executives, providing them with resources and services to launch and scale innovative brands. Redbud Brands emphasizes 'better-for-you' products and offers access to capital, a shared services platform featuring a network of experienced executives, and strategic relationships with retailers, distributors, and suppliers. This comprehensive support system is designed to empower entrepreneurs to build transformative and sustainable businesses that aim to make a positive impact on society.
Developer of AI governance platform designed to automate artificial intelligence oversight and risk management. The company's SaaS platform provides continuous and comprehensive regulatory compliance to measure, monitor, and manage AI-introduced risks at scale, enabling enterprises to build customer trust to unlock sales opportunities, differentiate with AI, and manage risks effectively to gain confidence in their deployments.
Speech Graphics Ltd provides procedural facial animation solutions to the entertainment industry. The company offers SGX, a production software solution that processes audio files and transcripts into facial animation. Its animations feature in various productions ranging from AAA video games to music videos, and are used in communication, training, and more. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Codoxo, also known as FraudScope, is a technology company that focuses on combating healthcare fraud, waste, and abuse through its artificial intelligence-based platform. Founded in 2016 and headquartered in Atlanta, Georgia, the company aims to enhance the allocation of healthcare funds by reducing fraudulent medical billing practices, which contribute to an estimated $272 billion in losses annually in the United States. Codoxo’s software platform employs advanced data analytics to detect, score, and rank suspicious claims, significantly improving upon traditional detection methods that often overlook fraud. The company's innovative Claims Intelligence technology, developed by researchers at the Georgia Institute of Technology, is capable of identifying evolving fraud schemes in real-time without relying on pre-existing fraud patterns. By utilizing data from the Centers for Medicare and Medicaid Services, Codoxo can proactively flag high-risk claims, thereby facilitating earlier interventions and ensuring healthcare resources are directed towards legitimate patient care.
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns.
Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Upgrade, Inc. operates an online lending platform that provides access to personal loans and an innovative credit card known as the Upgrade Card. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Phoenix, Arizona; Montreal, Canada; and Chicago, Illinois, Upgrade aims to serve mainstream consumers by combining credit products with free educational tools. These tools include credit health monitoring and resources to help users understand and manage their finances. The Upgrade Card offers responsible credit options similar to installment lending, making it accessible at numerous retail locations across the United States. Through its offerings, Upgrade seeks to empower consumers with both credit access and financial literacy.
Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success.
SafeBreach Inc. is a cybersecurity company that specializes in breach and attack simulation, providing organizations with tools to enhance their security posture. Founded in 2014 and based in Sunnyvale, California, with an additional location in Tel Aviv, Israel, SafeBreach offers a comprehensive platform that simulates hacker techniques to identify vulnerabilities within a network. Its platform utilizes an extensive Hacker's Playbook, which includes real-world breach methods, to proactively predict potential attacks and validate existing security controls. By integrating with various security information and event management systems and other cybersecurity tools, SafeBreach enables continuous visibility into security issues, allowing businesses to detect and remediate potential breaches before they can be exploited by actual attackers. The company is supported by notable investors, including Sequoia Capital and Deutsche Telekom Capital.
Mekonos Inc. engages in the design, development, and production of gene and cell therapies. The company develops integrated system-on-a-chip to develop predictive models for discovery and development. It develops MEMS, a technology that allows controlling individual nanoneedles to inject single cells, in a parallel architecture. Also, the company operates a cell-engineering platform. The company was founded in 2017 and is based in San Francisco, California
SafeRide, Inc. is a San Francisco-based company that develops a digital health platform and mobile application designed to facilitate non-emergency medical transport (NEMT) for patients. The platform allows healthcare providers to efficiently book and manage transportation, addressing issues such as appointment no-shows and future scheduling needs. Key features include the ability to send appointment reminders, real-time text alerts, and ride tracking, ensuring patient safety and quality service. SafeRide also offers tools to identify and monitor at-risk patients before they require critical care. Since its founding in 2015, the company has expanded its service network to include major cities such as Los Angeles, Seattle, Portland, St. Louis, and the greater New York area.
Prilenia Therapeutics B.V., a clinical stage biotech company, researches and develops products for movement disorders and neurodegenerative diseases affecting adults and children. It offers Pridopidine, an orally bioavailable small molecule investigational drug for huntington disease, amyotrophic lateral sclerosis, Parkinson’s disease levodopa induced dyskinesia, neurodegenerative eye disease, Parkinson’s disease, rett syndrome, fragile X, and Alzheimer’s disease. The company was founded in 2018 and is based in the Netherlands.
Bridgit Inc., founded in 2014 by civil engineer Lauren Lake and entrepreneur Mallorie Brodie, specializes in construction project management solutions. Headquartered in Kitchener, Canada, the company offers two primary products: Bridgit Bench and Bridgit Field. Bridgit Bench is a construction resource planning and workforce management tool designed to streamline the management of construction resources, eliminating the need for cumbersome spreadsheets. Bridgit Field focuses on enhancing communication, accountability, and visibility on construction sites, making project management more efficient and straightforward. By leveraging modern technology, Bridgit aims to simplify the complexities of construction projects, helping contractors and developers complete their work more effectively and on time.
Vesper Technologies Inc. is an electrical and electronic manufacturing company based in Boston, Massachusetts, specializing in the development and production of piezoelectric MEMS microphones. Founded in 2009, Vesper focuses on delivering innovative microphone solutions for various applications, including mobile handsets, tablets, and other audio-related products. The company's mission is to provide voice-powered solutions across diverse markets globally.
Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.
Elephas is a live tumor imaging diagnostics company focused on enhancing cancer treatment through personalized therapy determination. The company leverages advancements in cancer biology, multimodal microscopy, engineering, and artificial intelligence to analyze human live tumor fragments. This innovative platform aims to improve clinical decision-making for oncologists, enabling them to tailor treatments to individual patients. Additionally, Elephas seeks to accelerate drug development processes, addressing the urgent need for effective cancer therapies in a rapidly evolving healthcare landscape.
JumpCloud, Inc. operates a Directory-as-a-Service platform that simplifies and centralizes identity management for organizations. The company offers a Software-as-a-Service solution that automates server management tasks, including user management, patching, configuration, security, and compliance. With its cloud-based directory, JumpCloud enables the authentication, authorization, and management of users, devices, and applications across various environments, allowing IT teams to securely manage user identities and connect them to resources, regardless of the underlying provider or protocol. Users benefit from a single set of credentials to access their systems, applications, networks, and file servers, enhancing security and efficiency. Founded in 2010 and originally named SafeInstance, Inc., JumpCloud rebranded in 2013 and is headquartered in Louisville, Colorado.
Snyk Ltd. is a software as a service company that assists organizations in identifying and addressing vulnerabilities in open-source dependencies and container images. Founded in 2015 and headquartered in London, Snyk offers a developer-first security platform that includes Snyk Code, which provides static application security testing to enhance security visibility and remediation across various components of modern applications. The platform empowers developers to scan their code for vulnerabilities, offering alerts and guidance on remediation within their existing code editors. Snyk also provides tools for container vulnerability management, application security management, licensing compliance, and infrastructure as code security. By leveraging an internal database of software security flaws, Snyk helps organizations secure their applications throughout the development lifecycle. The company has established a strategic partnership with Rapid7 and operates additional offices in Tel Aviv, Boston, and Ontario.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.
Learn more about #paid’s creator media platform at www.hashtagpaid.com/product
DiCE Therapeutics, founded in 2013 and based in Menlo Park, California, specializes in developing a platform for the discovery of novel small molecules aimed at targets that have previously been difficult to address in the pharmaceutical sector. The company utilizes innovative technology that extends directed evolution, allowing for the direct translation of DNA-encoded information into organic compounds, thereby streamlining the traditionally labor-intensive processes of medicinal chemistry. This platform not only serves the pharmaceutical industry but also has applications in agriculture and materials sciences. The founding team includes notable figures such as Stanford Professor Pehr Harbury, who developed the core technology, and other experienced professionals from various sectors, contributing to the company's mission of transforming drug discovery and development.
Gusto is a company that provides a comprehensive web-based payroll and human resource management solution tailored for small and medium-sized businesses in the United States. Its online platform facilitates payroll processing, benefits management, and human resource services, offering features such as health insurance, workers’ compensation, 401(k) contributions, time tracking, and integration services. Gusto enables employers and employees to manage payroll and benefits conveniently through web-enabled devices. The platform also allows employees and contractors to access their pay stubs, payroll forms, and personal information. Founded in 2011 by Edward Kim, Joshua Reeves, and Tomer London in San Francisco, Gusto serves a diverse range of clients, including startups, healthcare providers, creative agencies, and retail businesses, with an additional office located in Denver, Colorado.
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.
Primer Technologies, Inc. specializes in developing advanced software that employs machine learning and natural language processing to analyze extensive datasets. The company's platform is designed to read and interpret documents in multiple languages, uncover insights, and generate automated reports that rival human analysis. By facilitating the understanding of vast amounts of text data, Primer assists governments and corporations in monitoring and making sense of global information. Founded in 2015 and headquartered in San Francisco, California, Primer aims to bridge the intelligence gap for businesses and enhance their ability to respond to emerging trends in the world.
Nubank issues, administrate, processes, and transfers payments related to post-paid credit cards and equity investment in other entities. It serves clients in Brazil. The company launched its proprietary loyalty rewards program ("Nubank Rewards"), as well as a digital account ("NuConta") that is already used by more than 17 million people. In Cristina Junqueira, David Velez, and Edward Wible founded EO2 Solucoes de Pagamento on May 6, 2013 that became Nubank in on June 25, 2013. It has its headquarters in São Paulo in Brazil.
Klaviyo, Inc. is a marketing automation and email platform that specializes in helping businesses grow through effective email marketing strategies. Founded in 2012 and headquartered in Boston, Massachusetts, with an additional office in London, Klaviyo provides a comprehensive suite of tools that includes email marketing software, segmentation capabilities, analytics, and customer profiling. The platform allows users to create personalized newsletters and automated emails, such as reminders for abandoned carts and order follow-ups, without requiring extensive resources. Klaviyo integrates seamlessly with various customer data sources, enabling businesses to manage data at scale, deliver engaging experiences across multiple channels, and measure marketing outcomes effectively.
Boom Sports is a technology company whose mission is to entertain and connect sports fans through games. After building the most popular real-money pick 'em daily fantasy product (2-time EGR app of the year), we're designing and operating world-class, free-to-play, games for media, league, and pro sports team partners. Our flagship product is NBC Sports Predictor, which offers fans in all 50 states the chance to win real money based on their (free) predictions. The product has been a huge success -- hundreds of thousands of active users, a 4.8 app store rating on 2K+ reviews -- and has provided a model for others that want to maximize the value of their audience in advance of legalized sports betting. If you want to build (legal) sports gaming products for the next generation of fans, come join us! We're hiring!
Tomorrow's Insights Today:
Spend less time on reporting and more time on executing. We built Tellius to make big data simple for the modern workforce. Cut through swathes of information and find the answers you’re looking for whether you’re an IT pro, marketing guru or C-level exec.
Tellius extends traditional self-service BI concepts through the use search-enabled visualizations and a proprietary recommendation engine that automates the basic interpretation and analysis of data.
Using machine learning, Tellius analyzes data to find hidden correlations, trends and anomalies which are then presented as a set of suggested visualizations and predictive models. Unlike traditional BI tools, Tellius is built on a distributed architecture (Apache Spark) which provides the scale and performance required for Big Data environments.
Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.
Earli is focused on transforming cancer detection and treatment by developing innovative technologies that enable early identification of tumors. The company specializes in creating synthetic biopsies, which are designed to induce cancer cells to produce non-human synthetic biomarkers. These biomarkers can be detected in biological samples such as blood, urine, or breath, allowing for the visualization of tumors that are typically too small to identify in traditional screenings. By leveraging these programmable genetic constructs, Earli aims to provide real-time data on cancer presence and progression, facilitating personalized treatment approaches and improving the chances of successful intervention. Overall, Earli's mission is to make the experience of cancer more manageable by ensuring timely detection and response.
DiCE Therapeutics, founded in 2013 and based in Menlo Park, California, specializes in developing a platform for the discovery of novel small molecules aimed at targets that have previously been difficult to address in the pharmaceutical sector. The company utilizes innovative technology that extends directed evolution, allowing for the direct translation of DNA-encoded information into organic compounds, thereby streamlining the traditionally labor-intensive processes of medicinal chemistry. This platform not only serves the pharmaceutical industry but also has applications in agriculture and materials sciences. The founding team includes notable figures such as Stanford Professor Pehr Harbury, who developed the core technology, and other experienced professionals from various sectors, contributing to the company's mission of transforming drug discovery and development.
Coagulo Medical Technologies, Inc. develops testing systems that detects, identifies, and quantifies the effect of all anticoagulants in whole blood and communicates actionable results to healthcare providers. The company is based in Auburndale, Massachusetts.
Uhnder Inc. is a technology company founded in 2015, specializing in innovative products for sensing, cognition, and communication, particularly within the Internet of Things (IoT) market. The company is headquartered in California, with engineering and operations based in Austin, Texas, and St. Louis, Missouri. Uhnder has developed a digital automotive radar-on-chip that aims to enhance safety and responsiveness in autonomous vehicles. This technology offers a more precise and reliable alternative to traditional light detection and ranging (lidar), which is commonly used for vehicle awareness. Uhnder's radar chip is designed to prevent collisions, provide alerts for potential hazards, and facilitate quick localization, thereby improving navigation and communication systems in vehicles.
Papercup is a London-based company that specializes in software designed to automatically translate voice tracks in videos using advanced machine learning techniques, including bayesian neural networks and speech synthesis. This innovative technology enables video creators to produce content in their original language while allowing users to translate the videos into their preferred languages. By making video content accessible to a global audience, Papercup empowers media companies, content creators, educational institutions, and international businesses to enhance the value of their content and reach an extensive audience of up to seven billion people.
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.
Acumen Pharmaceuticals is a biotechnology company dedicated to discovering and developing therapeutics and diagnostics for Alzheimer’s disease and related neurodegenerative conditions. Founded in 1996 and based in Livermore, California, the company focuses on creating ADDL-Select antibodies that specifically target soluble amyloid beta oligomers, which are considered major contributors to the progression of Alzheimer’s. Acumen employs a sensitivity assay to measure levels of these oligomers in cerebrospinal fluid, aiding in the selection of patients for clinical trials. The company holds a comprehensive portfolio of patents and intellectual property related to amyloid beta soluble oligomers. It has formed a partnership with Merck & Co. for the development of certain monoclonal antibody therapeutics. Additionally, Acumen has attracted investments from firms such as NeuroVentures LLC and Biotechnology Value Fund LP.
Scopely, Inc. is a global interactive entertainment company specializing in mobile and tablet games for casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely creates and publishes a diverse range of immersive gaming experiences based on both original and established franchises. Notable titles in its portfolio include Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, The Walking Dead: Road To Survival, YAHTZEE With Buddies, and Wheel of Fortune: Free Play. The company has garnered recognition for its rapid growth and innovation, achieving over $1 billion in lifetime revenue. With operations in various international locations, including Los Angeles, Barcelona, Dublin, and Tokyo, Scopely is supported by a skilled team and a proprietary technology platform that enhances its extensive portfolio of games.
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses.
It was founded in 2017 and is based in Cambridge, Massachusetts.
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses.
It was founded in 2017 and is based in Cambridge, Massachusetts.
Private Equity Round in 2020
BYJU’S is a valuable ed-tech company at USD 10.5 billion and the creator of India’s most loved school learning app which offers highly adaptive, engaging, and effective learning programs for students in classes 1 -12 and competitive exams like JEE, NEET, CAT, and IAS. BYJU'S launched its flagship product, BYJU’S - The Learning App, for classes 4-12 in 2015. Today, the app has over 42 million registered students. With an average time of 71 minutes being spent by a student on the app every day from 1700+ cities, the app is creating a whole new way of learning through visual lessons. The Disney. BYJU'S Early Learn App was launched in June 2019, a special offering from BYJU'S for students in classes 1-3 featuring Disney’s timeliness characters. In early 2019, BYJU'S also acquired Osmo, a Palo Alto-based maker of educational games to transform the whole offline to an online learning experience.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
Taysha Gene Therapies is a company focused on developing adeno-associated virus (AAV) based gene therapies aimed at treating monogenic diseases of the central nervous system. Founded in 2019 and based in Dallas, Texas, the company is advancing several therapeutic candidates, including TSHA-101 for GM2 gangliosidosis, TSHA-118 for CLN1 disease, TSHA-102 for Rett syndrome, TSHA-103 for SLC6A1 haploinsufficiency disorder, and TSHA-104 for Surfeit locus 1 deficiency. Taysha Gene Therapies collaborates with The University of Texas Southwestern Medical Center to enhance the development and commercialization of its innovative treatments, with a mission to eradicate severe and life-threatening CNS diseases through curative gene therapies. The company's expertise in drug development and its partnership with a leading gene therapy program enable it to effectively progress its pipeline of potential therapies.
Thrive Earlier Detection Corp. is a healthcare company dedicated to improving cancer detection through innovative technology. It focuses on the development of CancerSEEK, a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma to identify multiple types of cancer at their earliest stages, often before symptoms become apparent. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate early cancer detection into routine medical care. The company was previously known as Thrive Sciences Inc. and has been a subsidiary of Exact Sciences Corporation since early 2021. Thrive was launched with support from various investors, including Third Rock Ventures and Section 32, reflecting a strong commitment to advancing cancer diagnostics.
Bridgit Inc., founded in 2014 by civil engineer Lauren Lake and entrepreneur Mallorie Brodie, specializes in construction project management solutions. Headquartered in Kitchener, Canada, the company offers two primary products: Bridgit Bench and Bridgit Field. Bridgit Bench is a construction resource planning and workforce management tool designed to streamline the management of construction resources, eliminating the need for cumbersome spreadsheets. Bridgit Field focuses on enhancing communication, accountability, and visibility on construction sites, making project management more efficient and straightforward. By leveraging modern technology, Bridgit aims to simplify the complexities of construction projects, helping contractors and developers complete their work more effectively and on time.
ArcherDX, Inc. is a genomics company based in Boulder, Colorado, focused on advancing molecular pathology through next-generation sequencing technology. Established in 2013, the company develops and commercializes a range of research products, including DNA-based VariantPlex, RNA-based FusionPlex, ctDNA-based LiquidPlex, and RNA-based Immunoverse, aimed at optimizing therapy and monitoring cancer. ArcherDX also creates in-vitro diagnostic products and offers customizable assay design services to clinical and biopharmaceutical clients, enabling the development of new applications tailored to specific biomarker targets. The Archer platform utilizes proprietary Anchored Multiplexed PCR (AMP™) chemistry and sophisticated bioinformatics to enhance genetic mutation detection significantly. The company's products and services are utilized by academic and reference laboratories, biopharmaceutical firms, and contract research organizations, with ongoing efforts to gain regulatory approval for various companion diagnostic assays. As of October 2020, ArcherDX operates as a subsidiary of Invitae Corporation.
Scopely, Inc. is a global interactive entertainment company specializing in mobile and tablet games for casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely creates and publishes a diverse range of immersive gaming experiences based on both original and established franchises. Notable titles in its portfolio include Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, The Walking Dead: Road To Survival, YAHTZEE With Buddies, and Wheel of Fortune: Free Play. The company has garnered recognition for its rapid growth and innovation, achieving over $1 billion in lifetime revenue. With operations in various international locations, including Los Angeles, Barcelona, Dublin, and Tokyo, Scopely is supported by a skilled team and a proprietary technology platform that enhances its extensive portfolio of games.
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and delivery personnel in the United States and Canada. Founded in 2013 and headquartered in San Francisco, the company provides a marketplace that offers various services to help merchants with customer acquisition, delivery, analytics, merchandising, payment processing, and customer support. Through its DoorDash Drive service, the company also offers a white-label logistics solution. With a focus on transforming local businesses, DoorDash connects customers with their favorite restaurants in over 600 cities, enhancing the last-mile delivery infrastructure and fostering community connections.
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.
UiPath Inc. specializes in developing robotic process automation (RPA) software for enterprises, aiming to enhance operational efficiency through intelligent process automation. The UiPath platform enables organizations to discover automation opportunities, build and manage automations at scale, and optimize processes using artificial intelligence. Its offerings include tools such as UiPath Studio for designing automation processes, UiPath Orchestrator for managing enterprise tasks, and various robots for executing these processes across multiple applications. UiPath serves a diverse range of industries, including finance, healthcare, insurance, telecommunications, and manufacturing, by automating tasks such as claims processing, employee onboarding, and customer service. Founded in 2005, the company is headquartered in New York City, with additional offices in several global locations, including London, Bucharest, and Tokyo.
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis globally, including the United States, China, Japan, and Europe. Founded in 2012 and headquartered in Boston, Massachusetts, the company utilizes mass spectrometry technology to create handheld and desktop devices suitable for various applications in life sciences research, bioprocessing, industrial biotech, and forensics. Notable products include the MX908, a portable, battery-operated mass spectrometry device designed for the rapid analysis of unknown materials in various states; the Rebel, a desktop analyzer that provides real-time data on bioprocess environments; and the ZipChip, a high-resolution separation platform that enhances mass spectrometry sample analysis. 908 Devices aims to make the capabilities of mass spectrometry accessible beyond traditional laboratories, offering rugged and reliable tools for immediate field use.
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.
Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
Karuna Pharmaceuticals, Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston, Massachusetts.
Bridgit Inc., founded in 2014 by civil engineer Lauren Lake and entrepreneur Mallorie Brodie, specializes in construction project management solutions. Headquartered in Kitchener, Canada, the company offers two primary products: Bridgit Bench and Bridgit Field. Bridgit Bench is a construction resource planning and workforce management tool designed to streamline the management of construction resources, eliminating the need for cumbersome spreadsheets. Bridgit Field focuses on enhancing communication, accountability, and visibility on construction sites, making project management more efficient and straightforward. By leveraging modern technology, Bridgit aims to simplify the complexities of construction projects, helping contractors and developers complete their work more effectively and on time.
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
Allvision IO, Inc. is a software company based in Pittsburgh, Pennsylvania, founded in 2017. It specializes in developing a platform that aggregates various sources of three-dimensional data, utilizing machine learning and cloud computing to provide actionable insights. The company's offerings include high-definition, time-based maps for mobility, infrastructure, and transportation, as well as tools for asset detection, tracking, and compliance analysis. By enabling street-level analytics on a global scale, Allvision aims to connect decision-makers across industries such as transportation, engineering, government, and insurance with valuable spatial data, helping them address complex challenges and make informed decisions.
SeLux Diagnostics, Inc. is focused on advancing antibiotic susceptibility testing and infectious disease diagnostics through its innovative phenotyping platform. Founded in 2014 and located in Charlestown, Massachusetts, the company employs a unique synthetic amplifier technology that enhances the speed and complexity of antibiotic susceptibility testing. This platform significantly improves the accuracy and timeliness of diagnosing infections, enabling healthcare providers to prescribe targeted and personalized antibiotic therapies. By facilitating informed treatment decisions, SeLux Diagnostics aims to enhance patient care, save lives, and improve overall health outcomes in hospital settings.
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.
Acumen Pharmaceuticals is a biotechnology company dedicated to discovering and developing therapeutics and diagnostics for Alzheimer’s disease and related neurodegenerative conditions. Founded in 1996 and based in Livermore, California, the company focuses on creating ADDL-Select antibodies that specifically target soluble amyloid beta oligomers, which are considered major contributors to the progression of Alzheimer’s. Acumen employs a sensitivity assay to measure levels of these oligomers in cerebrospinal fluid, aiding in the selection of patients for clinical trials. The company holds a comprehensive portfolio of patents and intellectual property related to amyloid beta soluble oligomers. It has formed a partnership with Merck & Co. for the development of certain monoclonal antibody therapeutics. Additionally, Acumen has attracted investments from firms such as NeuroVentures LLC and Biotechnology Value Fund LP.
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.
NanoView Biosciences, founded in 2015 and based in Boston, Massachusetts, specializes in the development of innovative technologies for the characterization of extracellular vesicles, particularly exosomes. The company's proprietary ExoView technology uses an affinity microarray platform to enable specific binding and detection of these vesicles, facilitating high-throughput and cost-effective analysis. NanoView offers a range of products, including ExoView R100 and ExoView Tetraspanin, along with custom assays and sample services. The company's solutions aim to enhance research and the delivery of precision medicine by providing insights into the biological roles of exosomes and their potential as biomarkers for disease diagnosis, treatment, and monitoring.
Upgrade, Inc. operates an online lending platform that provides access to personal loans and an innovative credit card known as the Upgrade Card. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Phoenix, Arizona; Montreal, Canada; and Chicago, Illinois, Upgrade aims to serve mainstream consumers by combining credit products with free educational tools. These tools include credit health monitoring and resources to help users understand and manage their finances. The Upgrade Card offers responsible credit options similar to installment lending, making it accessible at numerous retail locations across the United States. Through its offerings, Upgrade seeks to empower consumers with both credit access and financial literacy.
Slack Technologies, Inc. operates a business technology software platform designed to enhance collaboration and productivity in workplaces. Headquartered in San Francisco, California, Slack connects people, applications, and data through its software-as-a-service model. The platform serves a diverse range of users, from Fortune 100 companies to small local businesses, facilitating seamless communication and information sharing among teams. Founded in 2009 and initially known as Tiny Speck, Inc., Slack has expanded its global presence with multiple offices worldwide. Additionally, Slack has established investment initiatives, including the Slack Fund, which supports startups focused on creating products that enhance workplace productivity.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
Vesper Technologies Inc. is an electrical and electronic manufacturing company based in Boston, Massachusetts, specializing in the development and production of piezoelectric MEMS microphones. Founded in 2009, Vesper focuses on delivering innovative microphone solutions for various applications, including mobile handsets, tablets, and other audio-related products. The company's mission is to provide voice-powered solutions across diverse markets globally.
Neptune Financial (NepFin) is a next-generation financial services company whose commercial lending platform provides growth capital to mid-sized American businesses. With its team's experience in technology, traditional leveraged finance, and online lending, the company is poised to transform the way that middle-market borrowers access debt financing. Based in San Francisco, NepFin is supported by the same early investors as SoFi, Funding Circle, Lending Club and Upgrade. For more information please visit www.nepfin.com.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Avitide, Inc. specializes in the discovery, manufacturing, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. The company focuses on developing customized affinity separation technology that streamlines bioprocess development, minimizes program risks, enhances predictability in commercial scalability, and lowers manufacturing costs. Its innovative affinity purification solutions cater to the production of various life-saving therapeutics, including enzymes, novel scaffolds, multi-specific antibodies, gene therapies, and vaccines. Incorporated in 2012 and based in Lebanon, New Hampshire, Avitide is recognized for its rapid development service timeline, positioning itself as a key player in the biopharmaceutical sector.
Scopely, Inc. is a global interactive entertainment company specializing in mobile and tablet games for casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely creates and publishes a diverse range of immersive gaming experiences based on both original and established franchises. Notable titles in its portfolio include Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, The Walking Dead: Road To Survival, YAHTZEE With Buddies, and Wheel of Fortune: Free Play. The company has garnered recognition for its rapid growth and innovation, achieving over $1 billion in lifetime revenue. With operations in various international locations, including Los Angeles, Barcelona, Dublin, and Tokyo, Scopely is supported by a skilled team and a proprietary technology platform that enhances its extensive portfolio of games.
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.
Upgrade, Inc. operates an online lending platform that provides access to personal loans and an innovative credit card known as the Upgrade Card. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Phoenix, Arizona; Montreal, Canada; and Chicago, Illinois, Upgrade aims to serve mainstream consumers by combining credit products with free educational tools. These tools include credit health monitoring and resources to help users understand and manage their finances. The Upgrade Card offers responsible credit options similar to installment lending, making it accessible at numerous retail locations across the United States. Through its offerings, Upgrade seeks to empower consumers with both credit access and financial literacy.
Agilis Biotherapeutics develops DNA therapeutics for patients with rare diseases of the central nervous system (CNS) that single-gene defects cause. Its technology enables precise targeting and restoration of lost gene function while avoiding unintended off-target effects.
Agilis Biotherapeutics also provides DNA therapeutics for patients with AADC Deficiency, a rare CNS disorder arising from reductions in the enzyme aromatic L-amino acid decarboxylase (AADC) that causes the inability to develop any motor strength and control resulting in breathing, feeding, and swallowing problems. Moreover, it offers DNA therapeutics for Friedreich’s Ataxia, a rare and life-shortening neurodegenerative disease caused by a single defect in the FXN gene, which causes reduced production of the frataxin protein, and DNA therapeutics for Angelman Syndrome (AS), a rare genetic, neurological disorder characterized by severe developmental delays.
Agilis Biotherapeutics has a strategic partnership with Intrexon Corporation. It began its operation in 2013, with its headquarters in Lynnfield, Massachusetts.
Funding Circle is a London-based online lending platform established in 2010 that connects investors with small and medium-sized businesses seeking capital. Operating in the United Kingdom, the United States, Germany, the Netherlands, and Spain, Funding Circle facilitates direct lending through its marketplace, allowing a variety of investors—including individuals, banks, local councils, and institutional investors—to fund business loans. The platform offers both secured and unsecured loans to help businesses with various financial needs, such as working capital, asset purchases, and property development. Additionally, Funding Circle collaborates with institutional investors on securitization programs and issues loan payment dependent debt securities. By bridging the gap between businesses in need of funding and investors seeking attractive returns, Funding Circle aims to create a mutually beneficial relationship that supports economic growth and job creation.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
Scopely, Inc. is a global interactive entertainment company specializing in mobile and tablet games for casual and core gamers. Founded in 2011 and headquartered in Culver City, California, Scopely creates and publishes a diverse range of immersive gaming experiences based on both original and established franchises. Notable titles in its portfolio include Star Trek Fleet Command, Looney Tunes World of Mayhem, WWE Champions, The Walking Dead: Road To Survival, YAHTZEE With Buddies, and Wheel of Fortune: Free Play. The company has garnered recognition for its rapid growth and innovation, achieving over $1 billion in lifetime revenue. With operations in various international locations, including Los Angeles, Barcelona, Dublin, and Tokyo, Scopely is supported by a skilled team and a proprietary technology platform that enhances its extensive portfolio of games.
Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.
AppDynamics is a developer of an observability platform focused on application performance management and mobile analytics. The platform is designed to provide real-time insights into application performance, user interactions, and overall business performance. By dynamically collecting millions of performance data points across applications and infrastructure, it enables organizations to proactively monitor and optimize complex software environments. AppDynamics employs advanced analytics to instantly identify performance anomalies and facilitate automatic fixes, ensuring continuous measurement of business impact. This capability is delivered in real-time, allowing for flexibility in deployment across cloud or on-premise environments. The emphasis on user interactions enhances customer engagement and improves operational efficiency, positioning AppDynamics as a critical tool for software-defined businesses seeking to enhance their digital performance.
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Qvella Corporation is a Toronto-based molecular diagnostics company established in 2009 by a team of scientists and engineers. The company focuses on advancing sample preparation and detection technologies in clinical microbiology, aiming to significantly reduce the time required to obtain results. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a unique electrical lysing method known as e-lysis™, allowing for the direct and fully automated rapid detection of infectious agents from unenriched biological samples. By providing actionable results in clinically relevant time frames, Qvella seeks to improve patient outcomes and transform medical practices in the field of microbiology.
Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Their specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Their suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. They also offer products designed specifically for ambulatory surgery centers.